BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31500815)

  • 1. Infliximab for Refractory Cardiac Sarcoidosis.
    Harper LJ; McCarthy M; Ribeiro Neto ML; Hachamovitch R; Pearson K; Bonanno B; Shaia J; Brunken R; Joyce E; Culver DA
    Am J Cardiol; 2019 Nov; 124(10):1630-1635. PubMed ID: 31500815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of infliximab in cardiac Sarcoidosis.
    Bakker ALM; Mathijssen H; Azzahhafi J; Swaans MJ; Veltkamp M; Keijsers RGM; Akdim F; Post MC; Grutters JC
    Int J Cardiol; 2021 May; 330():179-185. PubMed ID: 33582196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial Cardiac FDG-PET for the Diagnosis and Therapeutic Guidance of Patients With Cardiac Sarcoidosis.
    Ning N; Guo HH; Iagaru A; Mittra E; Fowler M; Witteles R
    J Card Fail; 2019 Apr; 25(4):307-311. PubMed ID: 30825644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis.
    Rosenthal DG; Parwani P; Murray TO; Petek BJ; Benn BS; De Marco T; Gerstenfeld EP; Janmohamed M; Klein L; Lee BK; Moss JD; Scheinman MM; Hsia HH; Selby V; Koth LL; Pampaloni MH; Zikherman J; Vedantham V
    J Am Heart Assoc; 2019 Sep; 8(18):e010952. PubMed ID: 31538835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.
    Ise T; Hasegawa T; Morita Y; Yamada N; Funada A; Takahama H; Amaki M; Kanzaki H; Okamura H; Kamakura S; Shimizu W; Anzai T; Kitakaze M
    Heart; 2014 Aug; 100(15):1165-72. PubMed ID: 24829369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Response to Tumor Necrosis Factor-α Inhibitor Therapy in the Management of Cardiac Sarcoidosis.
    Churchill R; Sykora D; Castrichini M; Arment C; Myasoedova E; Elwazir M; Bois J; Young K; Rosenbaum A
    Am J Cardiol; 2023 Oct; 205():20-27. PubMed ID: 37579656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of infliximab in severe chronic and refractory systemic sarcoidosis: a report of 16 cases.
    Chapelon-Abric C; Saadoun D; Biard L; Sene D; Resche-Rigon M; Hervier B; Costedoat-Chalumeau N; Drier A; Leger JM; Cacoub P
    Clin Exp Rheumatol; 2015; 33(4):509-15. PubMed ID: 26120779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of outcomes in patients with probable versus definite cardiac sarcoidosis.
    Takaya Y; Kusano KF; Nakamura K; Ito H
    Am J Cardiol; 2015 May; 115(9):1293-7. PubMed ID: 25743209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of cardiac sarcoidosis after radiofrequency ablation and placement of AICD- A propensity matched analysis.
    Bandyopadhyay D; Sahoo D; Zein J; Brunken RC; Tchou PJ; Culver DA
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):70-9. PubMed ID: 26237358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prednisone vs methotrexate in treatment naïve cardiac sarcoidosis.
    Vis R; Mathijssen H; Keijsers RGM; van de Garde EMW; Veltkamp M; Akdim F; Post MC; Grutters JC
    J Nucl Cardiol; 2023 Aug; 30(4):1543-1553. PubMed ID: 36640249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions.
    Nagai S; Yokomatsu T; Tanizawa K; Ikezoe K; Handa T; Ito Y; Ogino S; Izumi T
    Intern Med; 2014; 53(5):427-33. PubMed ID: 24583430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Imaging Response to Tumor Necrosis Factor Alpha Inhibitors in Treatment of Cardiac Sarcoidosis: A Multicenter Experience.
    Gilotra NA; Wand AL; Pillarisetty A; Devraj M; Pavlovic N; Ahmed S; Saad E; Solnes L; Garcia C; Okada DR; Constantinescu F; Mohammed SF; Griffin JM; Kasper EK; Chen ES; Sheikh FH
    J Card Fail; 2021 Jan; 27(1):83-91. PubMed ID: 32889044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The two extremes of cardiac sarcoidosis and the effect of Prednisone therapy.
    Armstrong D; Gonzalez-Stawinski GV; Ko JM; Hall SA; Roberts WC
    Am J Cardiol; 2015 Jan; 115(1):150-3. PubMed ID: 25456861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults.
    Nery PB; Beanlands RS; Nair GM; Green M; Yang J; McArdle BA; Davis D; Ohira H; Gollob MH; Leung E; Healey JS; Birnie DH
    J Cardiovasc Electrophysiol; 2014 Aug; 25(8):875-881. PubMed ID: 24602015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience.
    Elwazir M; Krause ML; Bois JP; Christopoulos G; Kendi AT; Cooper JLT; Jouni H; Abouezzeddine OF; Chareonthaitawee P; Abdelshafee M; Amin S
    J Card Fail; 2022 Feb; 28(2):247-258. PubMed ID: 34320381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular asynchrony in early isolated cardiac sarcoidosis.
    Nagai T; Arakawa J; Fujikawa A; Kastushika S
    Eur Heart J Cardiovasc Imaging; 2016 Jan; 17(1):40. PubMed ID: 26578651
    [No Abstract]   [Full Text] [Related]  

  • 17. Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis.
    Shelke AB; Aurangabadkar HU; Bradfield JS; Ali Z; Kumar KS; Narasimhan C
    Int J Cardiol; 2017 Feb; 228():717-722. PubMed ID: 27886616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?
    Mc Ardle BA; Birnie DH; Klein R; de Kemp RA; Leung E; Renaud J; DaSilva J; Wells GA; Beanlands RS; Nery PB
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):617-26. PubMed ID: 23884290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone.
    Yazaki Y; Isobe M; Hiroe M; Morimoto S; Hiramitsu S; Nakano T; Izumi T; Sekiguchi M;
    Am J Cardiol; 2001 Nov; 88(9):1006-10. PubMed ID: 11703997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance.
    Murtagh G; Laffin LJ; Beshai JF; Maffessanti F; Bonham CA; Patel AV; Yu Z; Addetia K; Mor-Avi V; Moss JD; Hogarth DK; Sweiss NJ; Lang RM; Patel AR
    Circ Cardiovasc Imaging; 2016 Jan; 9(1):e003738. PubMed ID: 26763280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.